Haleon
The Development Scientist supports formulation development for global OTC products within the Systemic Pain portfolio, focusing on the development and optimization of oral solid dosage formulations. This role involves designing and executing formulation studies, generating technical data, and collaborating across R&D functions to deliver projects that meet scientific, quality, regulatory, and business objectives. The position offers an opportunity to grow within a global OTC R&D organization while gaining exposure to products serving multiple international markets.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Haleon.
9% below the average for this role